Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study

Paul G. Richardson, Hans C. Lee, Al Ola Abdallah, Adam D. Cohen, Prashant Kapoor, Peter M. Voorhees, Axel Hoos, Karrie Wang, January Baron, Trisha Piontek, Julie Byrne, Scott Richmond, Roxanne C. Jewell, Joanna Opalinska, Ira Gupta, Sagar Lonial

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences